Psychiatry & Neurology, Child & Adolescent Psychiatry · South Bend, IN
NPI
1659335636
Since 2006
Specialty
Psychiatry & Neurology, Child & Adolescent Psychiatry
Code 2084P0804X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
107 N Eddy St
South Bend, IN, 46617
Phone (574) 246-1036
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
285 services
Medicare patients, 2024
80
Average age 57
Drug cost, 2024
$679K
4,501 prescriptions
Company payments, 2025
$1,640
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mitchell R Goldstein was code 99214 (office e&m - established), 192 times for 69 patients. In total Mitchell R Goldstein billed 285 services in 9 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 192 | 69 | $64.34 | $12K |
| 99213 Office E&M - Established | Office | 28 | 19 | $40.61 | $1,137 |
By year: 2022 $18K for 382 services; 2023 $18K for 362 services; 2024 $15K for 285 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mitchell R Goldstein prescribed most often to Medicare patients was Alprazolam, with 287 prescriptions and refills. In total Mitchell R Goldstein wrote 4,501 Medicare prescriptions that cost $679K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 287 | 341 | 33 | $2,304 |
| Clonazepam Generic | 261 | 278 | 35 | $1,348 |
| Sertraline Hcl Generic | 232 | 330 | 32 | $1,608 |
| Trazodone Hcl Generic | 210 | 341 | 30 | $1,206 |
| Quetiapine Fumarate Generic | 205 | 284 | 24 | $4,584 |
| Duloxetine Hcl Generic | 182 | 282 | 29 | $3,144 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 171 | 197 | 21 | $5,704 |
| Bupropion Xl Bupropion Hcl | 157 | 239 | 25 | $2,064 |
| Buspirone Hcl Generic | 140 | 288 | 30 | $2,531 |
| Lamotrigine Generic | 135 | 181 | 16 | $1,245 |
| Fluoxetine Hcl Generic | 112 | 144 | 13 | $922 |
| Divalproex Sodium Er Divalproex Sodium | 108 | 120 | Under 11 | $4,450 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 106 | 120 | 14 | $5,136 |
| Diazepam Generic | 106 | 114 | 11 | $646 |
| Lorazepam Generic | 85 | 99 | 13 | $888 |
Brand drugs: 291 claims; generic drugs: 4,210 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mitchell R Goldstein $1,640 ($1,640 in general payments such as food, travel and fees) from 13 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $526.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 17 | $526 |
| Alkermes, Inc. ALKS | 27 | $355 |
| Lundbeck LLC | 10 | $168 |
| Corium, LLC | 10 | $134 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $88.11 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $74.37 |
| Abbvie Inc. ABBV | 4 | $71.43 |
| Axsome Therapeutics, Inc. AXSM | 2 | $48 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $44.63 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $36.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.